First Time Loading...

Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 122.5 USD 0.5%
Updated: May 9, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

16.7B
-9%
Assets
Growth Rates:
1 Year
-31%
3 Years
+32%
5 Years
+826%
7 Years
-
10 Years
-
3.9B
-14%
Liabilities
Growth Rates:
1 Year
-26%
3 Years
-56%
5 Years
+987%
7 Years
-
10 Years
-
12.8B
-7%
Equity
Growth Rates:
1 Year
-32%
3 Years
+234%
5 Years
+786%
7 Years
-
10 Years
-

Balance Sheet Decomposition
Moderna Inc

16.7B
Assets
3.9B
Liabilities
16.7B
Assets
3.9B
Liabilities
Current Assets 9.6B
Cash & Short-Term Investments 8.5B
Receivables 387m
Other Current Assets 690m
Non-Current Assets 7.1B
Long-Term Investments 3.7B
PP&E 2.8B
Intangibles 95m
Other Non-Current Assets 583m
Current Liabilities 2.4B
Accounts Payable 183m
Accrued Liabilities 1.4B
Other Current Liabilities 776m
Non-Current Liabilities 1.5B
Long-Term Debt 575m
Other Non-Current Liabilities 957m

Balance Sheet
Moderna Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
50
135
658
236
2 624
6 848
3 205
2 907
Cash Equivalents
50
135
658
236
2 624
6 848
3 205
2 907
Short-Term Investments
1 008
621
863
867
1 984
3 879
6 697
5 697
Total Receivables
18
17
31
16
1 411
3 296
1 664
1 081
Accounts Receivables
14
13
13
5
1 391
3 175
1 385
892
Other Receivables
4
4
18
11
20
121
279
189
Inventory
0
0
0
0
47
1 441
949
202
Other Current Assets
11
11
11
9
233
607
916
438
Total Current Assets
1 087
783
1 563
1 129
6 298
16 071
13 431
10 325
PP&E Net
81
139
212
288
387
1 383
2 139
2 658
PP&E Gross
81
139
212
288
387
1 383
2 139
2 658
Accumulated Depreciation
28
48
64
95
120
352
658
433
Intangible Assets
0
0
0
0
0
0
0
44
Goodwill
0
0
0
0
0
0
0
52
Long-Term Investments
237
146
173
160
639
6 843
8 318
4 743
Other Long-Term Assets
12
16
14
13
13
372
1 970
604
Other Assets
0
0
0
0
0
0
0
52
Total Assets
1 417
N/A
1 084
-24%
1 962
+81%
1 589
-19%
7 337
+362%
24 669
+236%
25 858
+5%
18 426
-29%
Liabilities
Accounts Payable
28
21
31
7
18
302
487
520
Accrued Liabilities
25
73
79
71
476
1 518
2 136
1 823
Short-Term Debt
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
24
165
161
0
Other Current Liabilities
110
98
113
65
3 871
7 143
2 139
672
Total Current Liabilities
163
191
223
143
4 389
9 128
4 923
3 015
Long-Term Debt
13
16
33
39
110
599
912
575
Other Liabilities
400
252
176
233
277
797
900
982
Total Liabilities
575
N/A
459
-20%
432
-6%
415
-4%
4 775
+1 051%
10 524
+120%
6 735
-36%
4 572
-32%
Equity
Common Stock
1 177
1 177
0
0
0
0
0
0
Retained Earnings
366
622
1 007
1 496
2 244
9 958
18 320
13 606
Additional Paid In Capital
31
72
2 538
2 669
4 802
4 211
1 173
371
Unrealized Security Profit/Loss
0
0
1
2
3
0
362
114
Other Equity
0
1
0
0
0
24
8
9
Total Equity
842
N/A
625
-26%
1 530
+145%
1 175
-23%
2 561
+118%
14 145
+452%
19 123
+35%
13 854
-28%
Total Liabilities & Equity
1 417
N/A
1 084
-24%
1 962
+81%
1 589
-19%
7 337
+362%
24 669
+236%
25 858
+5%
18 426
-29%
Shares Outstanding
Common Shares Outstanding
324
324
329
337
399
403
385
382

See Also

Summary
MRNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRNA stock valuation using valuation multiples.
Wall Street Estimates
MRNA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.